SPI.L | Ticker Profile - Titan Protect

SPI.L

Spire Healthcare Group plc

Healthcare · Medical Care Facilities · LSE

$218.00

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$875M

Total market value of the company

Trailing P/E

54.63

Expensive — high growth expected

Forward P/E

16.19

Based on estimated future earnings — lower means cheaper

Rev Growth

+4.6%

Year-over-year revenue change

Profit Margin

1.0%

How much profit the company keeps from each dollar of revenue

ROE

2.3%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$275.00

+26% from current price — median analyst estimate

Recommendation

STRONG_BUY

Consensus view from 5 analysts covering this stock

About Spire Healthcare Group plc

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

https://www.spirehealthcare.com

Country: United Kingdom Employees: 17,800 Industry: Medical Care Facilities

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

0.098

Positive but modest risk-adjusted returns

Kelly Fraction

-0.0434

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.148

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-6.6%

Historical annualised return based on price data

Max Drawdown

-44.8%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.91

Less volatile than the market — more defensive

52W High

$256.50

15% below the year high

52W Low

$140.80

55% above the year low

Avg Volume

2,686,934

Average daily shares traded — higher means easier to buy and sell

Short Ratio

N/A

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

68.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$0.04

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

176.95

Heavy leverage — higher financial risk if revenues decline

Current Ratio

0.64

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.39

Like current ratio but excludes inventory — stricter test

Gross Margin

45.3%

Revenue left after cost of goods — higher means pricing power

Operating Margin

9.1%

Profit from core operations before interest and tax

Free Cash Flow

$66M

Positive — the business generates more cash than it spends

Revenue (TTM)

$1.6B

Total revenue over the last 12 months

Net Income

$16M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$300.00

Target Median

$275.00

Target Low

$179.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go